Cargando…

Unhealthy Behaviours and Risk of Parkinson’s Disease: A Mendelian Randomisation Study

BACKGROUND: Tobacco smoking and alcohol intake have been identified in observational studies as potentially protective factors against developing Parkinson’s disease (PD); the impact of body mass index (BMI) on PD risk is debated. Whether such epidemiological associations are causal remains unclear....

Descripción completa

Detalles Bibliográficos
Autores principales:	Heilbron, Karl, Jensen, Melanie P., Bandres-Ciga, Sara, Fontanillas, Pierre, Blauwendraat, Cornelis, Nalls, Mike A., Singleton, Andrew B., Smith, George Davey, Cannon, Paul, Noyce, Alastair J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609708/ https://www.ncbi.nlm.nih.gov/pubmed/34275906 http://dx.doi.org/10.3233/JPD-202487

Ejemplares similares

Bidirectional relationship between olfaction and Parkinson’s disease
por: Kim, Jonggeol J., et al.
Publicado: (2023)

Analysis of rare Parkinson’s disease variants in millions of people
por: Pitz, Vanessa, et al.
Publicado: (2023)

Evaluating Lipid‐Lowering Drug Targets for Parkinson's Disease Prevention with Mendelian Randomization
por: Williams, Dylan M., et al.
Publicado: (2020)

The Parkinson's Disease Mendelian Randomization Research Portal
por: Noyce, Alastair J., et al.
Publicado: (2019)

The Parkinson’s phenome—traits associated with Parkinson’s disease in a broadly phenotyped cohort
por: Heilbron, Karl, et al.
Publicado: (2019)

Parkinson’s disease determinants, prediction and gene–environment interactions in the UK Biobank
por: Jacobs, Benjamin Meir, et al.
Publicado: (2020)

Lower Lymphocyte Count is Associated With Increased Risk of Parkinson’s Disease
por: Jensen, Melanie P., et al.
Publicado: (2021)

A population scale analysis of rare SNCA variation in the UK Biobank
por: Blauwendraat, Cornelis, et al.
Publicado: (2020)

Mendelian Randomization — the Key to Understanding Aspects of Parkinson's Disease Causation?
por: Noyce, Alastair J., et al.
Publicado: (2015)

Polygenic Resilience Modulates the Penetrance of Parkinson Disease Genetic Risk Factors
por: Liu, Hui, et al.
Publicado: (2022)

Effect Modification between Genes and Environment and Parkinson's Disease Risk
por: Periñán, Maria Teresa, et al.
Publicado: (2022)

Tumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study
por: Kang, Xiaoying, et al.
Publicado: (2021)

The Parkinson's Disease DNA Variant Browser
por: Kim, Jonggeol J., et al.
Publicado: (2021)

Mendelian Randomization Study Shows No Causal Relationship Between Circulating Urate Levels and Parkinson’s Disease
por: Kia, Demis A., et al.
Publicado: (2018)

Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohorts
por: Dadu, Anant, et al.
Publicado: (2022)

Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study
por: Noyce, Alastair J., et al.
Publicado: (2017)

MIDN locus structural variants and Parkinson's Disease risk
por: Billingsley, Kimberley J., et al.
Publicado: (2020)

Unraveling the genetic complexity of Alzheimer disease with Mendelian Randomization
por: Bandres-Ciga, Sara, et al.
Publicado: (2019)

Insights on Genetic and Environmental Factors in Parkinson’s Disease from a Regional Swedish Case-Control Cohort
por: Brolin, Kajsa, et al.
Publicado: (2022)

Association of polygenic risk score with response to deep brain stimulation in Parkinson’s disease
por: Yoon, Esther, et al.
Publicado: (2023)

Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis
por: Bandres‐Ciga, Sara, et al.
Publicado: (2019)

Black and African American Connections to Parkinson's Disease Study: Addressing Missing Diversity in Parkinson's Disease Genetics
por: Bandres‐Ciga, Sara
Publicado: (2022)

Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
por: Billingsley, Kimberley J., et al.
Publicado: (2019)

Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson’s disease
por: Alvarez Jerez, Pilar, et al.
Publicado: (2023)

Type 2 Diabetes as a Determinant of Parkinson’s Disease Risk and Progression
por: Chohan, Harneek, et al.
Publicado: (2021)

Genetic risk factor clustering within and across neurodegenerative diseases
por: Koretsky, Mathew J, et al.
Publicado: (2023)

Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
por: Storm, Catherine S., et al.
Publicado: (2021)

Coding and Noncoding Variation in LRRK2 and Parkinson's Disease Risk
por: Lake, Julie, et al.
Publicado: (2021)

Gender Differences in the Prevalence of Parkinson's Disease
por: Zirra, Alexandra, et al.
Publicado: (2022)

RIC3 variants are not associated with Parkinson’s disease in large European, Latin American, or East Asian cohorts
por: Brolin, Kajsa, et al.
Publicado: (2022)

Functionalization of the TMEM175 p.M393T variant as a risk factor for Parkinson disease
por: Jinn, Sarah, et al.
Publicado: (2019)

Multi-modality machine learning predicting Parkinson’s disease
por: Makarious, Mary B., et al.
Publicado: (2022)

The Genetic Landscape of Parkinsonism-Related Dystonias and Atypical Parkinsonism-Related Syndromes
por: Diez-Fairen, Monica, et al.
Publicado: (2021)

Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease
por: Blauwendraat, Cornelis, et al.
Publicado: (2021)

The Parkinson's Disease Genome‐Wide Association Study Locus Browser
por: Grenn, Francis P., et al.
Publicado: (2020)

Immunogenetic Determinants of Parkinson’s Disease Etiology
por: Kung, Pin-Jui, et al.
Publicado: (2022)

Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease
por: Bandres-Ciga, S., et al.
Publicado: (2020)

Correction to: Large‑scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease
por: Bandres-Ciga, S., et al.
Publicado: (2021)

Mendelian randomisation analysis of the effect of educational attainment and cognitive ability on smoking behaviour
por: Sanderson, Eleanor, et al.
Publicado: (2019)

Role of obesity in smoking behaviour: Mendelian randomisation study in UK Biobank
por: Carreras-Torres, Robert, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nlnconp154o9eivrlsnfvsv9fh